Design and validation of a bifunctional ligand display system for receptor targeting.

Here we developed a bacteriophage display particle designed to serve as a bifunctional entity that can target tumors while delivering an agent. We engineered a chimera phage vector containing a pIII-displayed alphav integrins-targeting moiety and a pVIII-displayed streptavidin binding adaptor moiety. By using the chimeric phage particle, targeting of alphav integrins on cells in culture and tumor-related blood vessels was shown through different applications, including luminescent quantum dots localization, surface plasmon resonance-based binding detection, and an in vivo tumor model. The strategy validated here will accelerate the discovery and characterization of receptor-ligand binding events in high throughput, and cell-specific delivery of diagnostics or therapeutics to organs of choice without the need for chemical conjugation.

[1]  M. Bednarski,et al.  Tumor Regression by Targeted Gene Delivery to the Neovasculature , 2002, Science.

[2]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[3]  R. Haugland,et al.  Green- and red-fluorescent nanospheres for the detection of cell surface receptors by flow cytometry. , 1998, Journal of immunological methods.

[4]  M. Wilchek,et al.  Introduction to avidin-biotin technology. , 1990, Methods in enzymology.

[5]  R. Lerner,et al.  Phophabs: Antibody-phage-alkaline phosphatase conjugates for one step ELISA's without immunization , 1992 .

[6]  G. Winter,et al.  Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.

[7]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[8]  B. Katz,et al.  In Crystals of Complexes of Streptavidin with Peptide Ligands Containing the HPQ Sequence the pK a of the Peptide Histidine Is Less than 3.0* , 1997, The Journal of Biological Chemistry.

[9]  G. Hermanson.  Homobifunctional Cross-linkers , 1996 .

[10]  James McBride,et al.  Targeting cell surface receptors with ligand-conjugated nanocrystals. , 2002, Journal of the American Chemical Society.

[11]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[12]  Assaying Phage-Borne Peptides by Phage Capture on Fibrinogen or Streptavidin , 1997, Biological chemistry.

[13]  Erkki Ruoslahti,et al.  αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.

[14]  Patricia C. Weber,et al.  Crystal structure and ligand-binding studies of a screened peptide complexed with streptavidin. , 1992 .

[15]  G. P. Smith,et al.  A new filamentous phage cloning vector: fd-tet. , 1980, Gene.

[16]  H. Hoogenboom.  Overview of antibody phage-display technology and its applications. , 2002, Methods in molecular biology.

[17]  Kim-Anh Do,et al.  Steps toward mapping the human vasculature by phage display , 2002, Nature Medicine.

[18]  J. Foidart,et al.  FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells , 1998, Oncogene.

[19]  G. P. Smith,et al.  Libraries of peptides and proteins displayed on filamentous phage. , 1993, Methods in enzymology.

[20]  Wadih Arap,et al.  Biopanning and rapid analysis of selective interactive ligands , 2001, Nature Medicine.

[21]  Kim D Janda,et al.  A method for the generation of combinatorial antibody libraries using pIX phage display , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E Ruoslahti,et al.  RGD and other recognition sequences for integrins. , 1996, Annual review of cell and developmental biology.